PATIENT INSPIRED

Serial Number 85132426
Registration 4132631
800

Registration Progress

Application Filed
Sep 17, 2010
Under Examination
May 3, 2011
Approved for Publication
Mar 8, 2011
Published for Opposition
Mar 8, 2011
Registered
Apr 24, 2012

Trademark Image

PATIENT INSPIRED

Basic Information

Serial Number
85132426
Registration Number
4132631
Filing Date
September 17, 2010
Registration Date
April 24, 2012
Published for Opposition
March 8, 2011
Renewal Date
April 24, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Oct 16, 2022
Registration
Registered
Classes
005

Rights Holder

Alkermes, Inc.

03
Address
852 Winter Street
Waltham, MA 024511420

Ownership History

Alkermes, Inc.

Original Applicant
03
Waltham, MA

Alkermes, Inc.

Owner at Publication
03
Waltham, MA

Alkermes, Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Norman J. Rich

USPTO Deadlines

Next Deadline
2459 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2012-04-24)
Due Date
April 24, 2032
Grace Period Ends
October 24, 2032

Application History

36 events
Date Code Type Description Documents
Jan 1, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Oct 16, 2022 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Oct 16, 2022 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Oct 16, 2022 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Sep 30, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 6, 2022 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Apr 24, 2021 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Feb 8, 2018 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Feb 8, 2018 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Feb 8, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 24, 2018 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 28, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 28, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 17, 2012 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 24, 2012 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 20, 2012 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 19, 2012 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
Mar 12, 2012 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 5, 2012 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 2, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 7, 2012 IUAF S USE AMENDMENT FILED Loading...
Feb 7, 2012 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 28, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2011 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 26, 2011 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 26, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 5, 2011 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 3, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 8, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 8, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 28, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 28, 2011 ALIE A ASSIGNED TO LIE Loading...
Dec 28, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 26, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 22, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 21, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and compounds, namely, small molecules and chemical compounds for use in opioid modulation; pharmaceutical preparations and compounds for use in treating addiction, CNS disorders, [ pain and constipation] ; pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of the aforesaid diseases
First Use Anywhere: Dec 14, 2011
First Use in Commerce: Dec 14, 2011

Classification

International Classes
005